微质中的Apolipoprotein E聚合通过播种β-粉样症来启动阿尔茨海默病的病理学
Seiji Kaji1, Stefan A Berghoff1, Lena Spieth1
1Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Immunity
|October 17, 2024
概括
这就是阿尔茨海默病的原因.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 生物化学 生物化学
背景情况:
- 阿尔茨海默氏病 (AD) 的发病包括致病性蛋白质聚合物.
- 零星AD中的遗传联系涉及阿波利波蛋白E (APOE) 和微质功能.
- 阿尔茨海默病的病理级联的开始仍然不完全理解.
研究的目的:
- 调查阿波利波蛋白E (APOE) 聚合在阿尔茨海默病 (AD) 发病中的作用.
- 在AD模型和人类大脑中识别纤维状APOE聚合物.
- 阐明APOE聚合引发粉样蛋白-β (Aβ) 粉样症的机制.
主要方法:
- 生成一种转基因敲击鼠标模型,表达HaloTag标记的APOE.
- 对APOE净化生物化学协议的优化.
- 使用生物化学和染色技术识别和表征纤维状APOE聚合物.
主要成果:
- 纤维状APOE聚合物在患有粉样蛋白-β (Aβ) 粉样化症的小鼠和人类AD脑尸检中被确定.
- APOE聚合物染色为β型板结合染料呈阳性.
- 这些APOE聚合物在微质的内溶酶体系统中启动了Aβ粉样粉症,受脂质代谢和JAK/STAT信号的影响.
结论:
- 微质内细胞吸收和聚合APOE可以启动阿尔茨海默病中的Aβ斑块形成.
- 这项研究提出了一种新的模型,用于在阿尔茨海默病中Aβ氨基粉症的发病.
- 微质脂质代谢和JAK/STAT信号传递在APOE介导的Aβ氨基粉症中起作用.
更多相关视频
相关概念视频
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449


